Asian Spectator


The Times

.

ERBITUX(R) Approved for First-line Use in China in Patients W...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
DARMSTADT, Germany, Mar. 2, 2020 /PRNewswire-AsiaNet/-- Not intended for UK-based media- Approval is for ERBITUX(R) in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN- Pivotal Phase III study shows significant improvements with ERBITUX(R) in c...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Why Early Protection of Intellectual Assets is Critical

For many businesses, intellectual assets are among the most valuable things they own, yet they're often the last to receive formal legal protection. A brand name or a proprietary process can represe...

Konservasi gaya lama tak efektif: Pemulihan Aceh perlu warga dengan ekonomi yang merawat hutan

shutterstock(Manthofana/Shutterstock)● Peminggiran warga dari konservasi hutan Lingga Isaq menjadi salah satu faktor yang memperparah dampak bencana.● Pertanian monokultur dan tambang emas...

Tanggal kedaluwarsa produk kosmetik bukan akal-akalan ‘marketing’: Ada standar ilmiah di baliknya

● Tanggal kedaluwarsa menunjukkan batas waktu resmi sebuah produk masih dapat digunakan.● Period after opening (PAO) menandakan batas waktu aman produk boleh digunakan sejak kemasannya dib...

hacklink hack forum hacklink film izle hacklink testbets10sahabetGalabetagb99Galabet GirişSlot Siteleriefesbetcasinocasibom güncel girişzlibraryVikings İzlepokerklasTaraftarium24grandpsahabetjojobetjojobetjojobetbetparkjojobetJojobet